Skip to main content
Clinical Trials/NCT02117492
NCT02117492
Completed
Not Applicable

A Randomized Trial Comparing Horizontal and Vertical Vaginal Cuff Closure

Milton S. Hershey Medical Center1 site in 1 country70 target enrollmentMay 2014
ConditionsHysterectomy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hysterectomy
Sponsor
Milton S. Hershey Medical Center
Enrollment
70
Locations
1
Primary Endpoint
Vaginal Length
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the possible impacts of two techniques of vaginal cuff closure during robotic hysterectomy. We aim to compare vertical vs horizontal vaginal cuff closure and the impact that these techniques have on vaginal length, sexual function, and overall complication rates.

Detailed Description

A Validated questionnaire the Female Sexual Function Index (FSFI) and total vaginal lengths will be used to evaluate patients pre-operatively, at 4-6 weeks post-operatively, and 6 months post operatively. The FSFI will also be sent to the patient 12 months post operatively. These data will be used to assess sexual function and total vaginal length in patients undergoing minimally invasive hysterectomy. The study endpoint will occur after the 12 month follow-up questionnaire. Additionally, all complications following surgery will be tracked over the study period for comparison.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
May 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Timothy A Deimling

Minimally Invastive GYN Surgery

Milton S. Hershey Medical Center

Eligibility Criteria

Inclusion Criteria

  • Female premenopausal patients undergoing robot assisted total laparoscopic hysterectomy

Exclusion Criteria

  • Adults unable to consent
  • Children under the age of 18
  • Pregnant women
  • Post-menopausal women
  • Women with the known preoperative need for bowel or genitourinary surgery at the time of hysterectomy
  • Patients unable to consent to the procedure in the English language

Outcomes

Primary Outcomes

Vaginal Length

Time Frame: up to 4-6 weeks post-operative

The primary endpoint measured in the study will be total vaginal length. This will be measured preoperatively, at 4-6 weeks postoperatively.

Secondary Outcomes

  • Sexual Function(Pre-operative, 6 and 12 months post-operativey)

Study Sites (1)

Loading locations...

Similar Trials